Cargando…

Attenuated Postprandial GLP-1 Response in Parkinson’s Disease

The incretin hormone glucagon-like peptide 1 (GLP-1) has neuroprotective effects in animal models of Parkinson’s disease (PD), and GLP-1 receptor agonists are associated with clinical improvements in human PD patients. GLP-1 is produced and secreted by intestinal L-cells in response to consumption o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Manfready, Richard A., Engen, Phillip A., Verhagen Metman, Leo, Sanzo, Gabriella, Goetz, Christopher G., Hall, Deborah A., Forsyth, Christopher B., Raeisi, Shohreh, Voigt, Robin M., Keshavarzian, Ali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283566/ https://www.ncbi.nlm.nih.gov/pubmed/34276285 http://dx.doi.org/10.3389/fnins.2021.660942

Ejemplares similares

Gut microbial metabolites in Parkinson’s disease: Association with lifestyle, disease characteristics, and treatment status
por: Voigt, Robin M., et al.
Publicado: (2022)

An open label, non-randomized study assessing a prebiotic fiber intervention in a small cohort of Parkinson’s disease participants
por: Hall, Deborah A., et al.
Publicado: (2023)

Diet in Parkinson's Disease: Critical Role for the Microbiome
por: Jackson, Aeja, et al.
Publicado: (2019)

Intestinal Barrier Dysfunction in the Absence of Systemic Inflammation Fails to Exacerbate Motor Dysfunction and Brain Pathology in a Mouse Model of Parkinson's Disease
por: Jackson, Aeja, et al.
Publicado: (2022)

The Gastrointestinal Microbiome: Alcohol Effects on the Composition of Intestinal Microbiota
por: Engen, Phillip A., et al.
Publicado: (2015)

Single-Arm, Non-randomized, Time Series, Single-Subject Study of Fecal Microbiota Transplantation in Multiple Sclerosis
por: Engen, Phillip A., et al.
Publicado: (2020)

Systemic brain derived neurotrophic factor but not intestinal barrier integrity is associated with cognitive decline and incident Alzheimer’s disease
por: Voigt, Robin M., et al.
Publicado: (2021)

Colonic Epithelial Circadian Disruption Worsens Dextran Sulfate Sodium–Induced Colitis
por: Jochum, Sarah B, et al.
Publicado: (2022)

A Novel Dual-Frequency Deep Brain Stimulation Paradigm for Parkinson’s Disease
por: Karl, Jessica A., et al.
Publicado: (2019)

Deep nasal sinus cavity microbiota dysbiosis in Parkinson’s disease
por: Pal, Gian, et al.
Publicado: (2021)

High dose amantadine therapy may cause increased falling in patients with Parkinson's disease: A case report
por: Dames, Bridget, et al.
Publicado: (2020)

Long-Term Satisfaction and Patient-Centered Outcomes of Deep Brain Stimulation in Parkinson’s Disease
por: Karl, Jessica A., et al.
Publicado: (2018)

Circadian Disorganization Alters Intestinal Microbiota
por: Voigt, Robin M., et al.
Publicado: (2014)

The SARS-CoV-2 S1 Spike Protein Promotes MAPK and NF-kB Activation in Human Lung Cells and Inflammatory Cytokine Production in Human Lung and Intestinal Epithelial Cells
por: Forsyth, Christopher B., et al.
Publicado: (2022)

Vocal Responses to Perturbations in Voice Auditory Feedback in Individuals with Parkinson's Disease
por: Liu, Hanjun, et al.
Publicado: (2012)

Impact of alcohol-induced intestinal microbiota dysbiosis in a rodent model of Alzheimer’s disease
por: Frausto, Dulce M., et al.
Publicado: (2022)

Circadian Disruption: Potential Implications in Inflammatory and Metabolic Diseases Associated With Alcohol
por: Voigt, Robin M., et al.
Publicado: (2013)

Intestinal CYP2E1: A mediator of alcohol-induced gut leakiness
por: Forsyth, Christopher B., et al.
Publicado: (2014)

Minor Contribution of Endogenous GLP-1 and GLP-2 to Postprandial Lipemia in Obese Men
por: Matikainen, Niina, et al.
Publicado: (2016)

Light/Dark Shifting Promotes Alcohol-Induced Colon Carcinogenesis: Possible Role of Intestinal Inflammatory Milieu and Microbiota
por: Bishehsari, Faraz, et al.
Publicado: (2016)

The Approach to Sample Acquisition and Its Impact on the Derived Human Fecal Microbiome and VOC Metabolome
por: Couch, Robin D., et al.
Publicado: (2013)

Alcohol Induced Alterations to the Human Fecal VOC Metabolome
por: Couch, Robin D., et al.
Publicado: (2015)

Deep Brain Stimulation of the Subthalamic Nucleus in Patients with Parkinson Disease with Prior Pallidotomy or Thalamotomy
por: Khabarova, Elena A., et al.
Publicado: (2018)

Lower Neighborhood Socioeconomic Status Associated with Reduced Diversity of the Colonic Microbiota in Healthy Adults
por: Miller, Gregory E., et al.
Publicado: (2016)

Patient Knowledge and Attitudes towards Genetic Testing in Parkinson's Disease Subjects with Deep Brain Stimulation
por: Fraint, Avram, et al.
Publicado: (2019)

Effect of Concomitant Medications on the Safety and Efficacy of Extended-Release Carbidopa-Levodopa (IPX066) in Patients With Advanced Parkinson Disease: A Post Hoc Analysis
por: LeWitt, Peter A., et al.
Publicado: (2018)

Impact of Diabetes-Specific Nutritional Formulas versus Oatmeal on Postprandial Glucose, Insulin, GLP-1 and Postprandial Lipidemia
por: Mottalib, Adham, et al.
Publicado: (2016)

Evaluation of postprandial total triglycerides within the TIGG model for characterizing postprandial response of glucose, insulin, and GLP‐1
por: Leohr, Jennifer, et al.
Publicado: (2023)

A high carbohydrate, but not fat or protein meal attenuates postprandial ghrelin, PYY and GLP-1 responses in Chinese men
por: Parvaresh Rizi, Ehsan, et al.
Publicado: (2018)

Dietary Regulation of Gut-Brain Axis in Alzheimer’s Disease: Importance of Microbiota Metabolites
por: Frausto, Dulce M., et al.
Publicado: (2021)

Postprandial Increase in Mesenteric Blood Flow is Attenuated in Parkinson’s Disease: A Dynamic PC-MRI Study
por: Siebner, Thomas Hartwig, et al.
Publicado: (2021)

Disrupted Circadian Rest-Activity Cycles in Inflammatory Bowel Disease Are Associated With Aggressive Disease Phenotype, Subclinical Inflammation, and Dysbiosis
por: Swanson, Garth R., et al.
Publicado: (2022)

Nasopharyngeal Microbiota in SARS-CoV-2 Positive and Negative Patients
por: Engen, Phillip A., et al.
Publicado: (2021)

Increased Intestinal Permeability Correlates with Sigmoid Mucosa alpha-Synuclein Staining and Endotoxin Exposure Markers in Early Parkinson's Disease
por: Forsyth, Christopher B., et al.
Publicado: (2011)

GLP-1 and GLP-2 as Yin and Yang of Intestinal Lipoprotein Production: Evidence for Predominance of GLP-2–Stimulated Postprandial Lipemia in Normal and Insulin-Resistant States
por: Hein, Gustavo J., et al.
Publicado: (2013)

L‐Arginine Increases Postprandial Circulating GLP‐1 and PYY Levels in Humans
por: Amin, Anjali, et al.
Publicado: (2018)

Abnormal lipopolysaccharide binding protein as marker of gastrointestinal inflammation in Parkinson disease
por: Pal, Gian D., et al.
Publicado: (2015)

Long-Term Clinical Experience with Directional Deep Brain Stimulation Programming: A Retrospective Review
por: Karl, Jessica A., et al.
Publicado: (2022)

Using “Functional” Target Coordinates of the Subthalamic Nucleus to Assess the Indirect and Direct Methods of the Preoperative Planning: Do the Anatomical and Functional Targets Coincide?
por: Rabie, Ahmed, et al.
Publicado: (2016)

Improvement of Advanced Parkinson’s Disease Manifestations with Deep Brain Stimulation of the Subthalamic Nucleus: A Single Institution Experience
por: Rabie, Ahmed, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_551r01b4eak1lfktqrjl8p24ks